Efecto de distintas fertilizaciones de fósforo en la resistencia de brinzales de encina y alcornoque a "Phytophthora cinnamomi" Rands

El factor de contribución más virulento en el proceso de decaimiento forestal en el sur de la península ibérica es el Oomiceto Phytophthora cinnamomi Rands. Recientes investigaciones avalan el uso de fertilizaciones fosfóricas y fosfitos como fungicida contra Phytophthora cinnamomi. El objetivo general de este trabajo es estudiar el efecto de la fertilización fosfórica en brinzales de Quercus ilex y Q. suber sobre la resistencia a la podredumbre radical producida por P. cinnamomi. Se realizó un ensayo con brinzales de encina y alcornoque que previamente habían sido cultivados con un programa de fertilización fosfórica, dando lugar a cuatro tratamientos: Fosfato-A (3 mg P2O5 por planta), Fosfato-B (6 mg de P2O5 por planta), Fosfito (0,15 mg de P2O5 por planta) y no fertilizado. El ensayo se realizó en invernadero y tuvo una duración de 7 meses. Consistió en inocular las plantas de los distintos tratamientos con Phytophthora cinnamomi Rands. y estudiar la evolución de sus atributos morfológicos (altura, diámetro del cuello de la raíz y biomasa de raíz secundaria) y fisiológicos (contenido foliar de nutrientes). Los resultados mostraron que la fertilización con fosfatos no había mejorado la resistencia a la podredumbre radical causada por P. cinnamomi, mientras que el fosfito logró controlar totalmente la infección del patógeno, dando resultados negativos el reaislamiento de la especie fúngica inoculada en este tratamiento. Las plantas tratadas con fosfito presentaron un estado morfológico y fisiológico igual, y en algunos aspectos mejor, que el Control no inoculado. Se puede concluir que sería posible lograr una acción protectora frente a P. cinnamomi mediante el tratamiento con fosfitos durante el cultivo en vivero.The oomycete Phytophthora cinnamomi Rands is the mean responsible for oak decline in southern Spain. This paper investigates the relationship between phosphoric fertilization of Quercus ilex and Q. suber seedlings and resistance to the disease caused by Phytophthora cinnamomi. The study was conducted on holm oak and cork oak seedlings previously submitted to a phosphoric fertilization programme involving four different treatments, namely: Phosphate-A (3 mg P2O5 seedling), Phosphate-B (6 mg P2O5 seedling), Phosphite (0.15 mg de P2O5 seedling) and No Fertilization. Tests were conducted in greenhouse over a period of 7 months and a number of treatments to plants inoculated with Phytophthora cinnamomi Rands. were applied, assessing the changes in their morphological (viz. height, root and collar diameter, and secondary root biomass) and physiological characteristics (viz. leaf nutrient contents). Based on the results, phosphate failed to improve plant resistance to P. cinnamomi; by contrast, phosphite successfully avoided infection by this pathogen. In fact, the phosphitetreated plants exhibited a morphological and physiological status similar to or even better than that of the non-inoculated controls. The protective effect of phosphite against P. cinnamomi can be achieved by applying it during seedling cultivation in nurseries

Efecto de distintas fertilizaciones de fósforo en la resistencia de brinzales de encina y alcornoque a Phytophthora cinnamomi Rands.

The oomycete Phytophthora cinnamomi Rands is the mean responsible for oak decline in southern Spain. This paper investigates the relationship between phosphoric fertilization of Quercus ilex and Q. suber seedlings and resistance to the disease caused by Phytophthora cinnamomi. The study was conducted on holm oak and cork oak seedlings previously submitted to a phosphoric fertilization programme involving four different treatments, namely: Phosphate-A (3 mg P2O5 seedling), Phosphate-B (6 mg P2O5 seedling), Phosphite (0.15 mg de P2O5 seedling) and No Fertilization. Tests were conducted in greenhouse over a period of 7 months and a number of treatments to plants inoculated with Phytophthora cinnamomi Rands. were applied, assessing the changes in their morphological (viz. height, root and collar diameter, and secondary root biomass) and physiological characteristics (viz. leaf nutrient contents). Based on the results, phosphate failed to improve plant resistance to P. cinnamomi; by contrast, phosphite successfully avoided infection by this pathogen. In fact, the phosphitetreated plants exhibited a morphological and physiological status similar to or even better than that of the non-inoculated controls. The protective effect of phosphite against P. cinnamomi can be achieved by applying it during seedling cultivation in nurseries.El factor de contribución más virulento en el proceso de decaimiento forestal en el sur de la península ibérica es el Oomiceto Phytophthora cinnamomi Rands. Recientes investigaciones avalan el uso de fertilizaciones fosfóricas y fosfitos como fungicida contra Phytophthora cinnamomi. El objetivo general de este trabajo es estudiar el efecto de la fertilización fosfórica en brinzales de Quercus ilex y Q. suber sobre la resistencia a la podredumbre radical producida por P. cinnamomi. Se realizó un ensayo con brinzales de encina y alcornoque que previamente habían sido cultivados con un programa de fertilización fosfórica, dando lugar a cuatro tratamientos: Fosfato-A (3 mg P2O5 por planta), Fosfato-B (6 mg de P2O5 por planta), Fosfito (0,15 mg de P2O5 por planta) y no fertilizado. El ensayo se realizó en invernadero y tuvo una duración de 7 meses. Consistió en inocular las plantas de los distintos tratamientos con Phytophthora cinnamomi Rands. y estudiar la evolución de sus atributos morfológicos (altura, diámetro del cuello de la raíz y biomasa de raíz secundaria) y fisiológicos (contenido foliar de nutrientes). Los resultados mostraron que la fertilización con fosfatos no había mejorado la resistencia a la podredumbre radical causada por P. cinnamomi, mientras que el fosfito logró controlar totalmente la infección del patógeno, dando resultados negativos el reaislamiento de la especie fúngica inoculada en este tratamiento. Las plantas tratadas con fosfito presentaron un estado morfológico y fisiológico igual, y en algunos aspectos mejor, que el Control no inoculado. Se puede concluir que sería posible lograr una acción protectora frente a P. cinnamomi mediante el tratamiento con fosfitos durante el cultivo en vivero

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol:A prospective, multinational, observational study

Purpose To determine its cumulative incidence, identify the risk factors associated with Major Adverse Cardiovascular Events (MACE) development, and its impact clinical outcomes. Materials and methods This multinational, multicentre, prospective cohort study from the ISARIC database. We used bivariate and multivariate logistic regressions to explore the risk factors related to MACE development and determine its impact on 28-day and 90-day mortality. Results 49,479 patients were included. Most were male 63.5% (31,441/49,479) and from high-income countries (84.4% [42,774/49,479]); however, >6000 patients were registered in low-and-middle-income countries. MACE cumulative incidence during their hospital stay was 17.8% (8829/49,479). The main risk factors independently associated with the development of MACE were older age, chronic kidney disease or cardiovascular disease, smoking history, and requirement of vasopressors or invasive mechanical ventilation at admission. The overall 28-day and 90-day mortality were higher among patients who developed MACE than those who did not (63.1% [5573/8829] vs. 35.6% [14,487/40,650] p < 0.001; 69.9% [6169/8829] vs. 37.8% [15,372/40,650] p < 0.001, respectively). After adjusting for confounders, MACE remained independently associated with higher 28-day and 90-day mortality (Odds Ratio [95% CI], 1.36 [1.33–1.39];1.47 [1.43–1.50], respectively). Conclusions Patients with severe COVID-19 frequently develop MACE, which is independently associated with worse clinical outcomes

Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19:a multinational, multicentre study, prospective, observational study

Around one-third of patients diagnosed with COVID-19 develop a severe illness that requires admission to the Intensive Care Unit (ICU). In clinical practice, clinicians have learned that patients admitted to the ICU due to severe COVID-19 frequently develop ventilator-associated lower respiratory tract infections (VA-LRTI). This study aims to describe the clinical characteristics, the factors associated with VA-LRTI, and its impact on clinical outcomes in patients with severe COVID-19. This was a multicentre, observational cohort study conducted in ten countries in Latin America and Europe. We included patients with confirmed rtPCR for SARS-CoV-2 requiring ICU admission and endotracheal intubation. Only patients with a microbiological and clinical diagnosis of VA-LRTI were included. Multivariate Logistic regression analyses and Random Forest were conducted to determine the risk factors for VA-LRTI and its clinical impact in patients with severe COVID-19. In our study cohort of 3287 patients, VA-LRTI was diagnosed in 28.8% [948/3287]. The cumulative incidence of ventilator-associated pneumonia (VAP) was 18.6% [610/3287], followed by ventilator-associated tracheobronchitis (VAT) 10.3% [338/3287]. A total of 1252 bacteria species were isolated. The most frequently isolated pathogens were Pseudomonas aeruginosa (21.2% [266/1252]), followed by Klebsiella pneumoniae (19.1% [239/1252]) and Staphylococcus aureus (15.5% [194/1,252]). The factors independently associated with the development of VA-LRTI were prolonged stay under invasive mechanical ventilation, AKI during ICU stay, and the number of comorbidities. Regarding the clinical impact of VA-LRTI, patients with VAP had an increased risk of hospital mortality (OR [95% CI] of 1.81 [1.40-2.34]), while VAT was not associated with increased hospital mortality (OR [95% CI] of 1.34 [0.98-1.83]). VA-LRTI, often with difficult-to-treat bacteria, is frequent in patients admitted to the ICU due to severe COVID-19 and is associated with worse clinical outcomes, including higher mortality. Identifying risk factors for VA-LRTI might allow the early patient diagnosis to improve clinical outcomes. Trial registration: This is a prospective observational study; therefore, no health care interventions were applied to participants, and trial registration is not applicable

Search for squarks and gluinos with the ATLAS detector in final states with jets and missing transverse momentum using √s=8 TeV proton-proton collision data

A search for squarks and gluinos in final states containing high-p T jets, missing transverse momentum and no electrons or muons is presented. The data were recorded in 2012 by the ATLAS experiment in s√=8 TeV proton-proton collisions at the Large Hadron Collider, with a total integrated luminosity of 20.3 fb−1. Results are interpreted in a variety of simplified and specific supersymmetry-breaking models assuming that R-parity is conserved and that the lightest neutralino is the lightest supersymmetric particle. An exclusion limit at the 95% confidence level on the mass of the gluino is set at 1330 GeV for a simplified model incorporating only a gluino and the lightest neutralino. For a simplified model involving the strong production of first- and second-generation squarks, squark masses below 850 GeV (440 GeV) are excluded for a massless lightest neutralino, assuming mass degenerate (single light-flavour) squarks. In mSUGRA/CMSSM models with tan β = 30, A 0 = −2m 0 and μ > 0, squarks and gluinos of equal mass are excluded for masses below 1700 GeV. Additional limits are set for non-universal Higgs mass models with gaugino mediation and for simplified models involving the pair production of gluinos, each decaying to a top squark and a top quark, with the top squark decaying to a charm quark and a neutralino. These limits extend the region of supersymmetric parameter space excluded by previous searches with the ATLAS detector

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Background Up to 30% of hospitalised patients with COVID-19 require advanced respiratory support, including high-flow nasal cannulas (HFNC), non-invasive mechanical ventilation (NIV), or invasive mechanical ventilation (IMV). We aimed to describe the clinical characteristics, outcomes and risk factors for failing non-invasive respiratory support in patients treated with severe COVID-19 during the first two years of the pandemic in high-income countries (HICs) and low middle-income countries (LMICs). Methods This is a multinational, multicentre, prospective cohort study embedded in the ISARIC-WHO COVID-19 Clinical Characterisation Protocol. Patients with laboratory-confirmed SARS-CoV-2 infection who required hospital admission were recruited prospectively. Patients treated with HFNC, NIV, or IMV within the first 24 h of hospital admission were included in this study. Descriptive statistics, random forest, and logistic regression analyses were used to describe clinical characteristics and compare clinical outcomes among patients treated with the different types of advanced respiratory support. Results A total of 66,565 patients were included in this study. Overall, 82.6% of patients were treated in HIC, and 40.6% were admitted to the hospital during the first pandemic wave. During the first 24 h after hospital admission, patients in HICs were more frequently treated with HFNC (48.0%), followed by NIV (38.6%) and IMV (13.4%). In contrast, patients admitted in lower- and middle-income countries (LMICs) were less frequently treated with HFNC (16.1%) and the majority received IMV (59.1%). The failure rate of non-invasive respiratory support (i.e. HFNC or NIV) was 15.5%, of which 71.2% were from HIC and 28.8% from LMIC. The variables most strongly associated with non-invasive ventilation failure, defined as progression to IMV, were high leukocyte counts at hospital admission (OR [95%CI]; 5.86 [4.83–7.10]), treatment in an LMIC (OR [95%CI]; 2.04 [1.97–2.11]), and tachypnoea at hospital admission (OR [95%CI]; 1.16 [1.14–1.18]). Patients who failed HFNC/NIV had a higher 28-day fatality ratio (OR [95%CI]; 1.27 [1.25–1.30]). Conclusions In the present international cohort, the most frequently used advanced respiratory support was the HFNC. However, IMV was used more often in LMIC. Higher leucocyte count, tachypnoea, and treatment in LMIC were risk factors for HFNC/NIV failure. HFNC/NIV failure was related to worse clinical outcomes, such as 28-day mortality. Trial registration This is a prospective observational study; therefore, no health care interventions were applied to participants, and trial registration is not applicable

Search for supersymmetry in events with large missing transverse momentum, jets, and at least one tau lepton in 20 fb−1 of √s=8 TeV proton-proton collision data with the ATLAS detector

A search for supersymmetry (SUSY) in events with large missing transverse momentum, jets, at least one hadronically decaying tau lepton and zero or one additional light leptons (electron/muon), has been performed using 20.3fb−1 of proton-proton collision data at √s= 8 TeV recorded with the ATLAS detector at the Large Hadron Collider. No excess above the Standard Model background expectation is observed in the various signal regions and 95% confidence level upper limits on the visible cross section for new phenomena are set. The results of the analysis are interpreted in several SUSY scenarios, significantly extending previous limits obtained in the same final states. In the framework of minimal gauge-mediated SUSY breaking models, values of the SUSY breaking scale Λ below 63 TeV are excluded, independently of tan β. Exclusion limits are also derived for an mSUGRA/CMSSM model, in both the R-parity-conserving and R-parity-violating case. A further interpretation is presented in a framework of natural gauge mediation, in which the gluino is assumed to be the only light coloured sparticle and gluino masses below 1090 GeV are excluded

Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery

Peer reviewe

Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic